Binnovative Pharma Private Limited
About Binnovative Pharma Private Limited
Data last updated:
Binnovative Pharma Private Limited was a private limited company based in Nashik, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 18 March 2004.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH2004PTC145154. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Rekha Narendra Kotkar and Sunita Tushar Deore.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office was at F/No.02 Sr.No.792/12 P/No.23 Govindnager, Nashik, Maharashtra, India – 422009.
As per MCA filings, the company had satisfied charges of ₹2 Lakh on record.
Company details
Contact details
Binnovative Pharma Private Limited's registered office is in Nashik, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressF/No.02 Sr.No.792/12 P/No.23 Govindnager, Nashik, Maharashtra, India – 422009
- IndustryTrading, Wholesale, Other Wholesale
To see the full contact details of Binnovative Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Binnovative Pharma Private Limited
FY 2022 filings availableBinnovative Pharma Private Limited reported revenue of ₹500 for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 80% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Binnovative Pharma Private Limited, buy the company report.
Board of directors of Binnovative Pharma Private Limited
Binnovative Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rekha Narendra Kotkar | Director | 11 Jun 2019 | 7 Years 4 Months | As last reported |
| Sunita Tushar Deore Also directs: North Panacea LLP, North Panacea Sarthak LLP | Director | 08 Dec 2014 | 11 Years 10 Months | As last reported |
Auditor
Binnovative Pharma Private Limited is audited by VPN AND ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VPN AND ASSOCIATES | FY 2017 | 132074W |
Shareholding
The shareholding of Binnovative Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Binnovative Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Feb 2005 | 90349191 | Jalgaon Janata Sahakari Bank Ltd. | ₹2 Lakh | Satisfied |
To see the full charge records of Binnovative Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Binnovative Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Binnovative Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Binnovative Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Binnovative Pharma Private Limited, buy the company report.
Recent activity
Binnovative Pharma Private Limited has 5 board changes on record since 2014: 2 appointments and 3 cessations. The latest: Narendra Bhalchandra Kotkar ceased to be Director on 14 Jun 2019.
Frequently asked questions
Binnovative Pharma has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Binnovative Pharma was a private limited company based in Nashik, Maharashtra, India. The company worked in wholesale, within the trading industry. It was incorporated on 18 March 2004 and is registered under CIN U51397MH2004PTC145154. The company has been struck off by the Registrar of Companies and is no longer operational.
Binnovative Pharma had 2 directors:
- Rekha Narendra Kotkar - Director
- Sunita Tushar Deore - Director
The CIN (Corporate Identification Number) of Binnovative Pharma is U51397MH2004PTC145154. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Binnovative Pharma is at FNo.02 Sr.No.79212 PNo.23 Govindnager, Nashik, Maharashtra, India – 422009.
Binnovative Pharma was incorporated on 18 March 2004. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Binnovative Pharma on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
No. Binnovative Pharma has 1 GST registration on record and it is cancelled or inactive.
Binnovative Pharma operated in the trading industry, in the wholesale segment. It worked in this industry before it was struck off.
Narendra Bhalchandra Kotkar ceased to be Director on 14 Jun 2019. Tushar Tryambakrao Deore ceased to be Director on 14 Jun 2019. Nilesh Vijay Bagul ceased to be Director on 11 Jun 2019. Binnovative Pharma has 5 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
